List of Publications

1. M. Bingel, G. Lonnemann, S. Shaldon, K. M. Koch, C. A. Dinarello. Human interleukin-1 production during hemodialysis. Nephron 43: 161-163, 1986
   
   
2. M. Bingel, G. Lonnemann, K. M. Koch, C. A. Dinarello, S. Shaldon. Enhancement of in-vitro human interleukin-1 production by sodium acetate. Lancet 1:14-16, 1987
   
   
3. M. Bingel, G. Lonnemann, K. M. Koch, C. A. Dinarello, S. Shaldon. Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranes. Nephron 50: 273-276, 1988
   
   
4. M. Bingel, W. Arndt, M. Schulze, J. Flöge, S. Shaldon, K. M. Koch, G. Götze. Comparative study of C5a plasma levels with different hemodialysis membranes using an enzyme-linked immunosorbent assay. Nephron 51: 320-324, 1989
   
   
5. M. Haubitz, M. Schulze, K. M. Koch. Increase of C-reactive protein serum values following haemodialysis. Nephrol Dial Transplant 5: 500-503, 1990
   
   
6. M. Haubitz, U. Frei, U. Rother, R. Brunkhorst, K. M. Koch. Cyclophosphamide pulse therapy in Wegener´s Granulomatosis. Nephrol Dial Trans 6: 531-535, 1991
   
   
7. M. Haubitz, B. Klöppel, G. Lonnemann, B. Nonnast-Daniel. In vitro production of interleukin-1 from blood mononuclear cells of patients on chronic hemodialysis therapy. Clin Nephrol 38: 30-35, 1992
   
   
8. M. Haubitz, R. Brunkhorst, E. Wrenger, P. Froese, M. Schulze, K. M. Koch. Chronic induction of C-reactive protein by hemodialysis, but not by peritonealdialysis therapy. Peritoneal Dialysis Int 16: 158-162, 1996
   
   
9. M. Haubitz, V. Kliem, K. M. Koch, B. Nashan, H. J. Schlitt, R. Pichlmayr, R. Brunkhorst. Renal transplantation for patients with autoimmune diseases. Single-center Experience on 42 patients. Transplantation 63: 1251-1257, 1997
   
   
10. M. Haubitz, P. Schulzeck, S. Schellong, M. Schulze, K. M. Koch, R. Brunkhorst. Complexed plasma elastase as an in vivo marker for leucocyte activation in ANCA-associated vasculitis. Arthritis Rheumat 40: 1680-1684, 1997
    
    
11. M. Haubitz, K. M. Koch, R. Brunkhorst. Cyclosporine for the prevention of disease reactivation in relapsing ANCA-associated vasculitis. Nephrol Dial Transplant 13: 2074-2076, 1998
    
    
12. M. Haubitz, K. M. Koch, R. Brunkhorst. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener´s granulomatosis. Nephrol Dial Transplant 13: 1713-1718, 1998
    
    
13. M. Haubitz, S. Schellong, U. Göbel, H.J. Schurek, D. Schaumann, K.M. Koch, R. Brunkhorst. Intravenous cyclophosphamide pulse administration versus daily oral treatment in patients with ANCA-associated vasculitis and renal involvement. Arthritis Rheumat 41: 1835-1844, 1998
    
    
14. M. Haubitz, T. Busch, M. Gerlach, S. Schäfer, R. Brunkhorst, K. Falke, K.M. Koch, H. Gerlach. Exhaled nitric oxide in patients with Wegener´s granulomatosis. European Respir J 14: 113-117, 1999
    
    
15. M. Haubitz, R. Brunkhorst. C-reactive protein and chronic chlamydia pneumoniae infection- long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 16: 809-815, 2001
    
    
16. M. Haubitz, M. Gerlach, H.J. Kruse, R. Brunkhorst. Endothelial Tissue factor stimulation by proteinase 3 and elastase. Clin Exp Immunol 126: 584-588, 2001
    
    
17. M. Haubitz, F. Bohnenstengel, R. Brunkhorst, M. Schwab, U. Hofmann, D. Busse. The effects of renal insufficiency and hemodialysis on pharmacokinetics of cyclophosphamide in patients with autoimmune diseases. Kidney Int 61:1495-1501, 2002
    
    
18. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells are a new marker in ANCA-associated small-vessel vasculitis. Lancet (accepted for publication)